# A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients

> **NCT00920608** · PHASE1 · WITHDRAWN · sponsor: **AstraZeneca** · enrollment: 12 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** AZD9056
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00920608
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-05
- **Primary completion:** —
- **Final completion:** 2009-09
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2010-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00920608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00920608, "A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00920608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*